CLARUS THERAPEUTICS HOLDINGS, INC. Operating Cash Flow
CLARUS THERAPEUTICS HOLDINGS, INC. reported Operating Cash Flow of -$34.77 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-08-19
- CLARUS THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$17.50M.
- CLARUS THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$17.27M.
- CLARUS THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$9.33M.
- CLARUS THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2021-09-30 was -$12.52M.
- CLARUS THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$43.79M.
- CLARUS THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$41.58M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 7 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2022-06-30 | -$17.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | -$34.77M 10-Q · filed 2022-08-19 | -$44.10M derived: sum of 3 quarters · filed 2022-08-19 | -$56.62M derived: sum of 4 quarters · filed 2022-08-19 | |||
| 2022-03-31 | -$17.27M 10-Q · filed 2022-05-16 | -$26.60M derived: sum of 2 quarters · filed 2022-05-16 | -$39.12M derived: sum of 3 quarters · filed 2022-05-16 | -$54.01M derived: sum of 4 quarters · filed 2022-08-19 | |||
| 2021-12-31 | -$9.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$21.85M derived: sum of 2 quarters · filed 2022-03-31 | -$36.74M derived: sum of 3 quarters · filed 2022-08-19 | -$43.79M 10-K · filed 2022-03-31 | |||
| 2021-09-30 | -$12.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | -$27.41M derived: sum of 2 quarters · filed 2022-08-19 | -$34.45M 10-Q · filed 2021-11-19 | -$40.37M derived: sum of 4 quarters · filed 2022-08-19 | |||
| 2021-06-30 | -$14.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | -$21.93M 10-Q · filed 2022-08-19 | -$410.24K 10-Q · filed 2021-08-16 | -$27.85M derived: sum of 3 quarters · filed 2022-08-19 | |||
| 2021-03-31 | -$7.04M 10-Q · filed 2022-05-16 | -$226.58K 10-Q · filed 2021-05-26 | -$12.96M derived: sum of 2 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | -$5.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$28.11K 10-K · filed 2021-05-06 | -$41.58M 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | -$35.66M 10-Q · filed 2021-11-19 |